The present invention relates to new 2-piperazin-1-yl-4H-1,3-benzothiazin- 4-one derivatives and their use for the treatment of mammalian infections caused by bacteria, especially diseases like tuberculosis (TB), Buruli ulcer and leprosy that result from infection with closely related mycobacteria. (I).
Title
2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections
Date
2012
Note
Alternative title(s) :
(de) 2-piperazin-1-yl-4h-1,3-benzothiazin-4-on-derivate und ihre verwendung zur behandlung von infektionen bei säugetieren
(fr) Dérivés de 2-pipérazin-1-yl-4h-1,3-benzothiazin-4-one et leur utilisation dans le traitement des infections chez les mammifères
Other identifier(s)
EPO Family ID: 45349249
Record creation date
2015-09-22
